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A major challenge in preventing preterm birth (PTB) is identifying women at greatest
risk. This pilot study prospectively examined the differences in vaginal microbiota
and metabolite profiles of women who delivered prematurely compared to their term
counterparts in a cohort of asymptomatic (studied at 20–22, n = 80; and 26–28
weeks, n = 41) and symptomatic women (studied at 24–36 weeks, n = 37). Using
16S rRNA sequencing, the vaginal microbiota from cervicovaginal fluid samples was
characterized into five Community State Types (CST) dominated by Lactobacillus spp.:
CSTI (Lactobacillus crispatus), CSTII (Lactobacillus gasseri), CSTIII (Lactobacillus iners),
CSTV (Lactobacillus jensenii); and mixed anaerobes—CSTIV. This was then related to
the vaginal metabolite profile and pH determined by 1H-Nuclear Magnetic Resonance
spectroscopy and pH indicator paper, respectively. At 20–22 weeks, the term-delivered
women (TDW) indicated a proportion of CSTI-dominated microbiota >2-fold higher
compared to the preterm-delivered women (PTDW) (40.3 vs. 16.7%, P = 0.0002), and
a slightly higher proportion at 26–28 weeks (20.7 vs. 16.7%, P = 0.03). CSTV was
>2-fold higher in the PTDW compared to TDW at 20–22 (22.2 vs. 9.7%, P= 0.0002) and
26–28 weeks (25.0 vs. 10.3%, P = 0.03). Furthermore, at 26–28 weeks no PTDW had a
CSTII-dominated microbiome, in contrast to 28% of TDW (P < 0.0001). CSTI-dominated
samples showed higher lactate levels than CSTV at 20–22 weeks (P < 0.01), and 26–28
weeks (P < 0.05), while CSTII-dominated samples indicated raised succinate levels
over CSTV at 26–28 weeks (P < 0.05). These were supported by Principal coordinates
analysis, which revealed strong clustering of metabolites according to CST. In addition,
the CSTI-dominated samples had an average pH of 3.8, which was lower than those of
CSTII—4.4, and CSTV—4.2 (P < 0.05). Elevated vaginal lactate and succinate were
associated with predominance of CSTI and II over CSTV in women who delivered
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at term compared with their preterm counterparts. This suggests that
L. jensenii-dominance and decreased lactate and/or succinate could increase
the risk of PTB, while L. crispatus/gasseri may confer some protection against
inflammation-associated PTB and highlight the need for further study in this area.
Keywords: preterm birth, vaginal microbiome, community state types, metabolites, lactobacilli, lactate, succinate
INTRODUCTION
Preterm birth (PTB) is the leading contributor to infant mortality
andmorbidity globally with associated multi-billion dollar health
costs (MacDorman et al., 2007; Goldenberg et al., 2008; Blencowe
et al., 2013a,b). While much study has focused on the causes and
molecular mechanisms of PTB there are still major challenges in
identifying which women who are at risk of PTB. In addition
to a history of previous PTB, the increased expression of
fetal fibronectin in cervicovaginal fluid and a short cervix on
ultrasound are observations associated with risk of premature
delivery (DeFranco et al., 2013). However, these tests have limited
utility for accurate prediction of PTB, which occurs mostly in
women with no apparent risk factors. Indeed, it is estimated
that more than 60% of PTBs occur without identifiable cause
(Goldenberg et al., 2008). Up to half of all PTBs, however,
are associated with evidence of infection or inflammation in
gestational tissue (Knox and Hoerner, 1950; Goldenberg et al.,
2000).
Thus, in order to understand the mechanisms and prognostic
indicators of spontaneous PTB, there is a need to elucidate the
role of the vaginal microflora. In recent years, the role of human
microbiota in maintaining health and influencing disease has
become more prominent (Hajishengallis et al., 2011, 2012) with
advances in oral and gut microbiology clarifying healthy and
diseased phenotypes that may be manipulated to promote health
(Turnbaugh and Gordon, 2009; Cryan andDinan, 2012; DiGiulio
et al., 2015; Xu and Knight, 2015). For instance a link between
the composition of the vaginal microbiota and the risk of PTB
has been noted (Hillier et al., 1995). An increased risk of PTB
is associated with a shift from a health-associated microbiota
containing high levels of Lactobacillus spp., to a more diverse
microbiota containing raised levels of several anaerobic bacteria
such as Gardnerella,Mobiluncus, and various Bacteroidetes, such
as Bacteroides, Prevotella, and Porphyromonas spp. (Fredricks
et al., 2005; Hyman et al., 2005; Ravel et al., 2011; Fettweis
et al., 2014; DiGiulio et al., 2015) healthy microbiota is also
associated with maintenance of a low vaginal fluid pH (3–4.5) by
a mechanism that involves host factors as well as the production
of lactate by lactobacilli in the normal microflora (Linhares
et al., 2011; Witkin et al., 2013; Miller et al., 2016; Smith and
Ravel, 2016; Witkin and Linhares, 2016) In addition, lactobacilli
produce hydrogen peroxide and secrete various factors (such
as bacteriocins and anti-adhesive molecules against Gardnerella
vaginalis) that suppress growth of competing anaerobic
species.
Altered proportions of particular bacterial species within the
total microbiota affect the chemical composition of vaginal fluid
and epithelial cell behavior (Srinivasan et al., 2015; Vitali et al.,
2015). For example lactic acid levels are reduced in relation to
changes in the microbiota associated with bacterial vaginosis
(BV), while the levels of succinate, which is known to be
immunomodulatory (Al-Mushrif et al., 2000), or its potential
metabolic by-products (such as gamma-hydroxy-butyrate) are
reported to be elevated in some cases of BV (McMillan et al.,
2015).
However, in many cases BV is sub-clinical, difficult to
diagnose and has prevalence rates that differ by ethnicity,
being higher in black women (Fettweis et al., 2014). These
differences sometimes make the interpretation of published data
difficult due to conflicting results, limiting the identification of
suitable predictive markers for PTB. Moreover, the implications
of these microbiota-metabolite relationships are yet to be fully
explored in relation to spontaneous PTB. Therefore, one aim of
current work in the field has been to identify any significant,
potentially predictive, differences between the microbiota of
women delivering at term and that of women experiencing PTB.
The over-arching aim of this study was therefore to determine the
variation of the vaginal microbiota composition, and their basic
metabolite profiles, during the second trimester of pregnancy
and the association of these with eventual term or preterm (<37
weeks) birth outcomes.
Here, we present data characterizing the microbiota of a
cohort of women chiefly in their second trimester of pregnancy.
We also correlate these findings with differences in the profile
of a selection of metabolites, detected by 1H-Nuclear Magnetic
Resonance spectroscopy (NMR), that may indicate a biological
mechanism for the microbiota observations (Amabebe et al.,
2016a,b). This is because, it is not the mere presence or
distribution of the vaginal microflora, but also their interactions
with the host vaginal mucosal surface, resulting in metabolic
by-products, that can provide useful functional insight into
the pathophysiology of spontaneous PTB, as well as assist in
identifying women at greatest risk.
MATERIALS AND METHODS
These pilot prospective cohort studies were approved by the
Yorkshire & Humber (Sheffield) Committee of the National
Research Ethics Service (REC Number 13/YH/0167).
Subject Recruitment (Microbiota and
Metabolome Samples)
The study participants were recruited via the antenatal clinics
and the labor ward assessment unit of the JessopWing Maternity
Hospital, Sheffield, UK.
We recruited a cohort of pregnant women comprising those
presenting for antenatal care with no symptoms of preterm
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labor (Asymptomatic, n = 121 samples i.e., 20–22, n = 80;
and 26–28 weeks, n = 41) and those presenting to the delivery
suite with symptoms of threatened but not established preterm
labor (Symptomatic, n = 37 samples) (Figure 1). Many of the
women in the asymptomatic group (39%) had a previous history
of at least one PTB and were therefore at substantial risk of
recurrence. Their risk is increased by a factor of 2–6: the earlier
the gestation of the previous PTB, or the more the number of
previous PTBs, the higher the risk (Hoffman and Bakketeig, 1984;
Ekwo et al., 1992; Mercer et al., 1999; Ananth et al., 2006). This
asymptomatic group of women were studied between 20 and
22 weeks gestation when they presented for routine antenatal
visit. A subset of these women, mainly those with a previous
history of PTB (90%), consented to a further assessment at
26–28 weeks, when they re-attended the antenatal clinic. This
enabled us to determine whether the microbiota patterns varied
in individual women between mid and late second trimester.
In addition to this asymptomatic cohort, women attending the
labor ward assessment unit with symptoms of threatened, but
not established, preterm labor (regular uterine contractions but
cervix not dilated beyond 3 cm) between 24 and 36 weeks,
consented and provided vaginal swab samples and were included
in our “total” cohort. In parallel, we also set out to assess the
metabolite profile and vaginal fluid pH of these patients in the
same samples.
Collection of Samples
Following written informed consent, clinical research staff
obtained two high vaginal swab (HVS) samples from the
posterior vaginal fornix with dry polystyrene Dacron swabs
FIGURE 1 | Classification of total study sample population according to
presence of symptoms of preterm labor and gestational age at sampling (n =
158).
(Deltalab Eurotubo 300263, Fisher Scientific, UK) from each
woman after the passage of a sterile vaginal (Cusco’s) speculum.
To obtain adequate amounts of CVF, each swab was rolled in
a clockwise direction and moved across the posterior fornix
for a minimum of 1 min, the first swab being employed
for microbiome studies and the second for metabolite assays.
The collected samples were immediately processed or stored
at −20◦C for up to 3 days pending analysis: one swab
was used for DNA extraction and the other for metabolite
analysis. In addition, a third HVS was sent for routine clinical
microbiological culture and sensitivity tests for BV and urinary
tract infections.
During vaginal fluid sample collection, the vaginal pH was
also determined from a sample of vaginal discharge obtained by
a dry swab, which was then smeared on a narrow range pH paper
(Ph-Fix, Macherey-Nagel).
DNA Extraction
Swabs were rinsed in 400µl of PBS (Sigma) and underwent
vortex mixing for 5min. Two-fifty microliters of swab eluate
was transferred to a clean tube and incubated with 1.5mg/ml
lysozyme (sigma) for 1 h at 37◦C. DNA was extracted using
the QIAamp DNA mini kit column (Qiagen) according to the
manufacturer’s instructions. Purified DNA was eluted from the
QIAamp kit column in 100µl of ultrapure water and stored at
−20◦C until further processing.
16S rRNA PCR and 454 Pyrosequencing
A 500 bp region of the 16S rRNA gene (covering V1–V3) was
PCR-amplified from 5 ng of extracted DNA sample using primers
comprising universal 16S primers 27F (Frank et al., 2008) and
519R (Lane et al., 1985) along with Roche GS-FLX Titanium
Series adapter sequences (A & B) for 454 pyrosequencing.
The forward primers incorporate 12 base unique barcode
sequences (5′-CCATCTCATCCCTGCGTGTCTCCGACTCAG-
NNNNNNNNNNNN-AGAGTTTGATYMTGGCTCAG-3′) to
enable pooling of samples in the same sequencing run. The
appropriate barcoded A-27F and the B-519R (5′-CCTATCC
CCTGTGTGCCTTGGCAGTCTCAG-GWATTACCGCGGC
KGCTG-3′) primers were used in PCRs with PHUSION Hi-
Fidelity DNA polymerase (Thermo Scientific). For the reaction
conditions, there was an initial denaturation step of 30 s at 98◦C
followed by 25 cycles of 98◦C for 10 s, 50◦C for 30 s, 72◦C for 1
min, and a final extension of 72◦C for 10 min. PCR amplicons
were initially checked using agarose gel electrophoresis and
purified using Ampure magnetic beads according to the
manufacturer’s instructions. Amplicon quantification, QC,
pooling, and unidirectional sequencing of the samples was
performed using the Lib-L kit and the Roche 454 GS-FLX
+ Titanium series sequencer by the DNA sequencing facility
(Dr. Shilo Dickens), Department of Biochemistry, Cambridge
University, Cambridge, UK.
Availability of Data and Material
Our data has been submitted to the NCBI with SRA accession
number SRP065627.
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Sequence Analysis
Analysis of sequences was carried out using the mothur analysis
suite v1.34.0 (Schloss et al., 2009) based on the Schloss standard
operating procedure (SOP) (Schloss et al., 2011). Sequences
were first de-noised using AmpliconNoise algorithm (Quince
et al., 2011) as implemented by mother. After de-noising, any
sequences that were <400 bp in length and/or had one of the
following:>2mismatches in the primer,>1mismatch in barcode
regions, and homopolymers of >8 bases, were removed from
the dataset. The remaining sequences were trimmed to remove
the primers and barcodes and aligned to the SILVA 16S rRNA
reference alignment (Pruesse et al., 2007). The Uchime algorithm
(Edgar et al., 2011) was used to identify and remove chimeric
sequences. Diversity of the communities was calculated using
Simpson’s inverse diversity index (Simpson, 1949) and the total
OTU richness of the communities was estimated using Chao 1
(Chao, 1984) and CatchAll (Bunge, 2011). The thetaYC metric
(Yue and Clayton, 2005) was used to generate distance matrices
in mother, which were visualized as dendograms and Principal
Coordinates Analysis (PCoA) plots. PCoA plots were generated
in R using the rgl package. Sequences were then classified using a
naïve Bayesian classifier within mothur with a bootstrap cutoff
of 80% using the Vaginal 16S rDNA Reference Database from
Fettweis et al. (2012).
Additionally, sequences were clustered into Operational
Taxonomic Units (OTUs) at a sequence dissimilarity distance of
0.03 using an average neighbor algorithm, again using themothur
package. Samples were sub-sampled (again usingmothur to equal
that of the library with the fewest sequences for subsequent
OTU-based analyses (2,000)—an action that in the case of
our data did not compromise richness or increase rarefaction)
(Supplementary Table S1). A heat map comparing samples
based on the relative abundances of species-level taxa (species
included comprised at least 1% of the community in at least
one sample) was generated using Morpheus (https://software.
broadinstitute.org/morpheus/) with hierarchical clustering via a
Pearson method according to sample composition.
Comparative Statistics for CST-Level Data
Given the non-normal and complex nature of vaginal
communities (low diversity index with most samples dominated
by only one OTU that is present at >95% of the overall
population), there were many counts of zero. Therefore, the
method used for the analysis was to create a binary variable
based on whether the species made up at least half of the
sample (count ≥1,000—and thus assigned a Community State
Types, CST). This method was independently selected by health
statistics experts at the Statistical Services Unit, University of
Sheffield (Director, Sara Hilditch). The proportion of women
for whom the species made up at least half of their microbiota
was compared between the women who subsequently delivered
preterm and those who delivered at term, i.e., the proportions
of the dominant CST defining OTUs (CSTs I, II, III, V).
Confidence intervals were obtained for the estimated difference
in proportions (Laud and Dane, 2014), and a 2-sided P-value
was calculated, all using proprietary code within the R-package.
A significance level of 5% was considered valid. Fisher’s exact test
was also applied to contingency tables reflecting the % of each
sample made up of each CST (I, II, III, V).
As microbiota and metabolite profiles may vary with
gestation, we analyzed the data at specific gestational time point
ranges. However, in some of our additional analyses when
assessing pH and metabolites in relation to CST we also pooled
term and preterm samples and included samples collected from
the labor ward assessment unit into “total” cohorts since the
comparator in that case was CST against metabolite or pH and
not gestation at assessment.
Metabolite Sample Preparation
A swab-end obtained at the same time and anatomical location
as the microbiota swab was suspended in 600µl of PBS (sigma,
Tissue culture grade) and vortexed for 5min to wash the CVF
into solution. The swab was disposed of safely afterwards. The
eluate was then centrifuged at 13,000 rpm for 3min to separate
swab particles and any cellular material from the vaginal fluid
solution. The supernatant was carefully aspirated into a separate
clean 1.5ml microfuge tube and stored at −80◦C until analysis.
Prior to 1H-NMR analysis, 380µl of eluate was mixed with
20µl of deuterium oxide (D2O) and transferred into a 5mm
NMR tube (Norell, Marion, NC). With new batch of samples
and swabs, several unused (sterile) polystyrene Dacron swabs
were also prepared and analyzed identically as background signal
controls, taking into account any manufacturer batch variation
changes—no changes were noted. To compare metabolite levels
between term and preterm pregnancy outcomes and between
CST groupings we used t-tests (with Welch’s correction) and
ANOVA (with Tukey’s multiple comparisons test), as indicated,
since, unlike the OTU abundance data the metabolite data
were normally distributed (as tested by a D’Agostino & Pearson
omnibus test using the software GraphPad Prism package v7).
1H-NMR Spectroscopy
Using a 9.4T Bruker Avance III NMR spectrometer (Bruker
BioSpin GmbH, Karlsruhe, Germany), with 5 mm broadband
observe probe, 1H-NMR spectra were acquired using the
Watergate water suppression pulse sequence (NS = 256, D1 =
5 s, AQ = 1 s, SW = 20.6 ppm, TD = 16,446), for each vaginal
sample (Hwang and Shaka, 1995). All 1H-NMR experiments were
performed at 21◦C.
Data was acquired and processed using Bruker Topspin 2.1.6
software to produce a phase and baseline corrected spectrum. In
order to assign metabolites to the 1H-NMR spectra, 2-D NMR
spectra were obtained: 1H-1Hwatergate-double quantum filtered
correlation spectroscopy (DQFCOSY) – NS = 256, D1 = 0.5
s, AQ = 0.832 × 0.022 s, SW = 9.0 × 9.0 ppm, TD = 6,000
× 160; 1H-13C presat-heteronuclear single quantum correlation
spectroscopy (HSQC) – NS = 1,024, D1 = 1 s, AQ = 0.078
× 0.006 s, SW = 10.0 × 150 ppm, TD = 624 × 180; 1H-
13C presat-heteronuclear multiple bond correlation spectroscopy
(HMBC) – NS = 1,024, D1 = 1 s, AQ = 0.128 × 0.005 s, SW
= 10.0 × 230 ppm, TD = 1,024 × 200; and 1H-1H presat-clean
total correlation spectroscopy (TOCSY) – NS = 16, D1 = 1.5 s,
AQ = 0.284 × 0.071 s, SW = 9.0 × 9.0 ppm, TD = 2,048 ×
512. All spectra were referenced to the 1H lactate signal at δ =
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1.30 ppm. A Representative 1-D 1H-NMR spectrum is shown in
Supplementary Figure S1.
Identified metabolite signals in the 1H-NMR spectra were
integrated for peak area (which is proportional to metabolite
concentration). To correct for differences in vaginal fluid
concentration (variation in the swab sample volumes), each
metabolite integral was divided by the total spectrum integral (δ
= 0.0–10.0 ppm, excluding the residual water signal between δ
= 4.7–5.0 ppm) to provide a normalized integral (N.I.), which is
reported throughout this manuscript (Bai et al., 2012; Gajer et al.,
2012; Amabebe et al., 2016a,b).
Multivariate analysis (linear and logistic regressions) was
performed to determine associations between study metabolites
and CST subtypes and delivery outcomes.
RESULTS
The demographic, pregnancy, and delivery outcome details
of study participants are summarized in Table 1 (and
Supplementary Table S2). Only 16% of all samples were
obtained from smokers and 84% of the women were White. We
obtained 158 samples from 133 women (including all women
studied before 28 weeks), 26 of whom delivered preterm (37
samples) whilst 107 delivered at term (121 samples); and those
symptomatic women studied after 28 weeks but before 36 weeks
(n= 25).
Community Level Microbiota Analysis
From our 158 barcoded 16S rRNA gene amplicon samples, we
obtained a final dataset of 1,264,109 high quality sequences (of
which 10,199 were unique) with a mean length of 442 bases
after quality filtering, and alignment to the SILVA reference
database, screening of the alignment, and removal of chimeras.
This provided a final mean yield of 8,000 sequences per sample
for further analysis.
The number of observed OTUs (at a distance of 0.03) per
sample after sub-sampling to 2,000 sequences per sample ranged
from 1 to 80 (median = 15). The median estimated coverage of
the communities according to Good’s non-parametric coverage
calculator was 99.5% at this sequencing depth. The diversity
(Simpson’s inverse diversity index) of the communities is shown
in Figure 2A, but reveals no significant difference between any
of the sample groups i.e. gestational weeks or term versus
preterm. Chao1 estimates of total OTU richness for term versus
preterm (total, 20–22 weeks and 26–28 weeks) are shown in
Figure 2B and were predictably low given the nature of the
vaginal microbiota. For example, Chao estimates ranged between
2 and 160 OTUs (with a median of around 30) across all samples
(Figure 2).
Comparison of the overall bacterial community structure
of vaginal swab samples from term and preterm women were
performed using the thetaYC metric from which a distance
matrix was constructed and visualized using PCoA. As shown in
Figure 3, there was no significant clustering of samples based on
their overall community structure.
Assignment of Community State Type labels
As has been observed in other studies of the vaginal
microbiota, analysis of the OTUs in each sample revealed
microbial communities that were dominated by Lactobacillus
spp. (Figure 4). In fact heat-mapping of the OTU abundance in
each sample, followed by non-biased hierarchical clustering of
TABLE 1 | Patient level clinical cohort data.
Total cohort
(n = 133)
Total term
(n = 107)
Total
preterm
(n = 26)
20–22 weeks
(n = 80)
20–22 weeks
term (n = 62)
20–22 weeks
preterm
(n = 18)
26–28 weeks
total (n = 41)
26–28 w
term
(n = 29)
26–28 weeks
preterm
(n = 12)
Age (mean, years) 28.8 28.2 31.6 30.1 29.6 32 29.3 28.9 30.2
Prev. PTB (%) 35.3 24.3 80.8 38.8 25.8 83.3 80.5 72.4 100
ETHNICITY
White 82.7 85 73 86.3 91.9 66.6 75.6 75.9 83.3
Black 6 2.8 19.2 7.5 1.6 27.7 9.8 3.4 16.6
Asian 3 3.7 0 2.5 3.2 0 4.9 6.9 0
Mixed 2.3 2.8 0 1.3 1.6 0 2.4 3.4 0
No data 6 5.6 7.7 2.5 1.6 5.5 7.3 10.3 0
Smoker (%) 15.8 15 19.2 12.5 8 27.7 12.2 10.3 16.6
Vaginal pH N/C N/C N/C 4 3.97 4.06 4.1 4.06 4.2
Cervical. length (mm) N/C N/C N/C 37.7 39.2 32 31.3 34 25.45
CST
CSTI *31.8 33.6 *28 35 40.3 16.6 19.5 20.7 16.6
CSTII *11.4 11.2 *12 11.3 9.7 16.6 19.5 27.6 0
CSTIII *43.2 43.9 *40 38.8 38.7 38.8 41.5 34.5 58.3
CSTV *9.8 8.4 *16 12.5 9.7 22.2 14.6 10.3 25
Other *3.8 2.8 *8 2.5 1.6 5.5 4.9 6.9 0
N/C, average vaginal pH and cervical length values were not calculated due to different values occurring from samples from different stages of gestation from the same patients. Women
studied after 28w (n = 25) are not included in this table (see Supplementary Table S2).
*Calculated with patient 20 (P20) data removed as CST changed from V to III between sampling. N.B. sample level data provided in Supplementary Table S2.
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FIGURE 2 | Diversity (A) and Richness (B) of samples as derived using Inverse-Simpson and Chao1 methods, respectively.
FIGURE 3 | Principal Coordinates Analysis (PCoA) 3D plot of term vs. preterm for All women (A) (% proportion of variance attributable to each axis, PC1 = 22.1, PC2
=11.2, PC3 = 8.5), 20–22 week (B), and 26–28 week (C), Preterm = red, Term = blue. The PCoA was used to explore and visualize any similarities or dissimilarities
in relation to delivery outcomes.
the data (using Morpheus) reveals that, like other studies, the
communities fall into several distinct clusters that are termed
“community state-types” (CSTs) that map onto the abundance
of various lactobacilli and other species (Ravel et al., 2011;
Gajer et al., 2012). We then assigned CSTs along the lines of
previous work (Ravel et al., 2011) with a community dominated
by >50% (±5 and 10% higher than next OTU abundance) of
OTUs from one Lactobacillus species, giving a CST accordingly
(CSTI—Lactobacillus crispatus, CSTII— Lactobacillus gasseri,
CSTIII— Lactobacillus iners, CSTIV—mixed anaerobes, CSTV—
L. jensenii). Using this division system we observed that among
all the samples combined CSTIII (L. iners, 41.14%) was the most
abundant, followed by CSTI (L. crispatus, 29.75%), CSTII (L.
gasseri, 12.66%), CSTV (L. jensenii, 12.02%), CSTIII/V (L. iners
and L. jensenii, 1.9%), Streptococcus anginosus (1.26%), CST∗
(Lactobacillus delbrueckii and Lactobacillus helveticus 1.33%),
and CSTIV (mixed anaerobes, 0.63%). These assignments were
confirmed by repeating the PCoA analyses with samples assigned
to CSTs, where, as shown in Figure 5, the CST groups clearly
cluster together in the 3D-plots.
CST categorization of the samples confirmed that vaginal
microbiota of women at 20–22 weeks who were resampled
at 26–28 weeks continued to be dominated by the same
species of Lactobacillus, with one exception where the woman’s
CST assignments changed between 20–22 and 26–28 weeks.
In the latter case, the microbiota CST changed from ∼40:52
(iners:jensenii) at 20 weeks to ∼61:38 (iners:jensenii) at 27
weeks gestation [Supplementary Table S2, patient 20, P20 (A)
and (B)] and showed a mixed lactobacillus population. In
addition we found only a small percentage of samples dominated
by mixed anaerobes (0.63%, containing, Prevotella amnii and
Prevotella timonensis, alongside Lachnospiracae BVAB1 and
Escherichia coli). Two samples were dominated by S. anginosus
(a milleri-group Streptococcus) (1.3%), while only three of the
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FIGURE 4 | Heatmap of bacterial species composition illustrating hierarchical clustering of data based on OTU level assignment of trimmed data, with community
state type highlighted on the left hand side (bar) CSTI (Lactobacillus crispatus, blue), CSTII (L. gasseri, red), CSTIII (L. iners, green), CSTIV (mixed anaerobes, purple),
CSTV (L. jensenii, orange), CST III/V (50/50 mixed population), Streptococcus anginosus (navy blue). Dark red colors indicate high abundance according to the key
with each row representing a patient sample. Raw data can be found in Supplementary Table S1 (tabs therein).
samples (1.9%) did not show dominance by a single species of
Lactobacillus, i.e., these samples instead contained approximately
equal proportions of L. iners (CSTIII) and L. jensenii (CSTV) and
as a result have been annotated as CSTIII/V.
Relationship between CST and Outcome
When we analyzed CST assignment in relation to birth outcome
in our cohorts, we used both a simple Fisher’s exact test, as
employed by Kindinger et al. (2017) and a much more stringent,
alternative test based on the method of Laud and Dane (2014).
In terms of data, we observed a greater proportion (>2-fold)
of CSTI (L. crispatus) dominated microbiota present in the
term than the preterm groups at 20–22 weeks (40.32 vs. 16.66%
respectively, Fisher’s exact test, P = 0.0002) and a slightly
higher proportion in the 26–28 weeks group (20.69 vs. 16.66%
respectively, P = 0.03) (Figure 6). Conversely, the proportion
of patients’ vaginal samples that were categorized as CSTV (L.
jensenii dominant) was more than 2-fold lower in the term
than preterm groups at 20–22 (9.68 and 22.22% respectively,
P= 0.0002) and 26–28 weeks groups (10.34 and 25% respectively,
P = 0.03). Also, at 26–28 weeks none of the preterm patient
samples were dominated by CSTII (L. gasseri) in contrast to 28%
of term patients (P < 0.0001). When the Laud and Dane method
was used, these data were supported at 26–28 weeks, with the
lack of CSTII in the patients in the preterm group, P = 0.03.
Also there was a trend toward a higher proportion of CSTI in the
term women compared to their preterm counterparts (P= 0.06),
again in support of our observations above. Overall, using both
statistical methods, there appears to be a link between CSTI—L.
crispatus and L. gasseri and health.
Relationship between CST and Vaginal pH
It is well-established that vaginal pH varies in relation to health
with a pH of 3–4.5 considered a signature of a healthy vaginal
environment and variations upwards a sign of an imbalanced
vaginal environment, e.g., onset of BV (Linhares et al., 2011;
Smith and Ravel, 2016;Witkin and Linhares, 2016). As a result we
measured the vaginal fluid pH of 130 of the 158 samples obtained
(N.B. decreased sample population due to lack of patients’
consent/data). Our data showed pH-values ranged between 3.6
and 6.1 with a mean value of 4.04 (Supplementary Table S3).
We then ascertained whether there was any relationship between
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pH and CST assignment (Figure 7A). Samples assigned as CSTI
(L. crispatus) had an average pH of 3.83, with one-way ANOVA
analysis revealing that this was significantly lower than samples
assigned as CSTII (L. gasseri) and CSTV (L. jensenii) which had
mean pH values of 4.38 and 4.19, respectively (P < 0.05). One-
way ANOVA analysis also revealed that the mean pH of CSTII
samples (L. gasseri) was significantly higher than that of CSTIII
(L. iners), at 4.38 and 4.03, respectively (P < 0.05).
Relationship between Outcome and pH
While we see that the mean pH is always lower in the groups
that ultimately delivered at term compared to the corresponding
FIGURE 5 | Principal Coordinates Analysis (PCoA) 3D plot colored for CST
across the whole cohort as follows: CST* = red, CST1 = blue, CST2 = green,
CST3 = gray, CST3/5 = yellow, CST4 = black, CST5 = turquoise, Other =
brown. The PCoA was used to explore and visualize any similarities or
dissimilarities in relation to CST dominance with the % proportion of variance
attributable to each axis being PC1 = 22.1, PC2 = 11.2, PC3 = 8.5.
preterm groups (Figure 7B) (20–22 weeks: term = 3.97, preterm
= 4.06; 26–28 weeks: term = 4.06, preterm = 4.2), this
observation was not found to be statistically significant when we
performed ANOVA analysis, but may be confirmed with larger
sample cohorts.
Metabolic Profiling of Our Cohort
As outlined above we collected parallel samples for microbiota
and metabolite data from the same patients under identical
conditions. We then performed basic 1H-NMR analyses for
the six identified metabolites (lactate, glucose, acetate, alanine,
succinate, glutamate/glutamine) from these samples, plotting
spectra for samples that were then normalized to overall area
under the spectrum for each metabolite peak as previously
described by our group (Amabebe et al., 2016a). From these data
(n = 156), we examined the levels of the metabolites in term and
preterm women from the same cohorts as for our microbiota
studies.Within this data (Supplementary Table S4), we observed
that at 26–28 weeks gestation, women who ultimately delivered
preterm had significantly lower (about 2-fold) succinate levels
compared to the term women (P = 0.04, two-tailed t-test, Welch
correction) (Figure 8A).
Since we had already identified that the CST profiles of
our term and preterm groups differ, observing that L. jensenii
and L. crispatus might be associated with differing outcomes in
our cohorts, we then analyzed our metabolite data in relation
to CST, using the normalized integrals and One-way ANOVA
with Tukeys multiple comparison test applied. As shown in
Figures 8B,C, we observed significantly higher lactate levels
(1.7-fold higher) in CSTI (L. crispatus)-dominated samples
compared to those dominated by CSTV (L. jensenii) (P <
0.01). These differences were replicated for lactate when the
groups were analyzed according to gestational age at sampling,
with CSTI showing significantly higher lactate than CSTV-
dominated samples at both 20–22 weeks (P < 0.01), and
26–28 weeks (P < 0.05) (Figure 9A). We also observed 4-
fold higher succinate integrals in our total cohort between
CSTI and CSTV (P < 0.001), and although the trend was
the same in the subsets categorized by gestational time point
FIGURE 6 | Stacked bar-charts showing CST within total and sub-cohorts showing % of total [number of women in each group (n) shown] in each of the CSTs
assigned where at least 60% of a sample is composed of a single species of Lactobacillus or at least 10% greater than the next most abundant. CSTI (L. crispatus,
blue), CSTII (L. gasseri, red), CSTIII (L. iners, green), CSTIV (mixed anaerobes, purple), CSTV (L. jensenii, orange), CSTIII/V (50/50 mixed population), Group B (Milleri)
Streptococci (navy blue) in relation to OTU within normalized trimmed sequencing samples. Total sample population, n = 158. CST* (Lactobacillus delbrueckii and
L. helveticus).
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FIGURE 7 | (A) Bar plots showing CST in relation to mean vaginal pH (with SEM), (*P < 0.05, ****P < 0.0001). (B) Vaginal pH of total and sub-cohort (no significant
differences).
FIGURE 8 | (A) Normalized metabolite data for succinate for preterm vs. term in 26–28 week cohort and (B,C) Metabolite integrals plotted in relation to CST for the
total study cohort (i.e., 20–22 and 26–28 week combined). *P < 0.05, ***P < 0.001, ****P < 0.0001.
of the studies, it did not reach statistical significance. For
CSTII (L. gasseri), we observed 3- to 5-fold raised succinate
levels over CSTV in the total cohort (P < 0.0001), at 20–
22 weeks (ns) and at 26–28 weeks (P < 0.05) (Figure 9A).
These associations were supported by Principal Component
Analysis of metabolite data from the entire cohort, which
revealed strong clustering according to the CSTs (Figure 9B).
Multivariate (logistic regression) analysis showed that the other
metabolites i.e., glucose, acetate, alanine, glutamate/glutamine
had no significant correlations with either CST or delivery
outcomes in this unique cohort.
DISCUSSION
For the first time, we highlight important links betweenmicrobial
community state-types and targeted metabolite profiles in
relation to PTB, thereby highlighting the potential functional
and clinical significance of combining these determinations to
improve our understanding of the mechanisms of inflammation-
associated PTB. We show that community composition (defined
as community state type, or CST) seems to differ between
women who delivered at term and those who delivered
preterm.
This study presents data from vaginal fluid samples of a
population of asymptomatic and symptomatic pregnant women
studied across mid-trimester, many of who had a previous history
of PTB but with a low prevalence of BV or any other genital
infection. We analyzed the vaginal microbiota using 16S rRNA
gene sequencing while collecting data on pH and metabolite
expression levels. Our aim was 3-fold, firstly, to identify any
changes in vaginal microbiota early in pregnancy in women
who subsequently deliver preterm and to establish baseline
information about the microbiota of these cohorts. Secondly, we
examined whether any identified changes in microbiota related
to wider functional changes in the vaginal microenvironment
(i.e., metabolites and pH). Thirdly, we determined if insight
could be gleaned from vaginal microbial and metabolite
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FIGURE 9 | (A) Normalized metabolite data for lactate (upper) and succinate (lower) at 26–28 weeks and 20–22 weeks (AU, arbitrary units, *P < 0.05, **P < 0.01,
***P < 0.001, ****P < 0.0001). (B) PCoA 3D plot of CST with respect to metabolite levels generated using Metaboanalyst software.
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profiles of pregnant women in mid-trimester regarding
subsequent PTB.
In relation to the microbiota, it has been established that
the vaginal microbiota is relatively simple, i.e., in most cases it
is dominated by a single Lactobacillus spp. (Ravel et al., 2011;
Gajer et al., 2012), and exists in a number of CST classified
by dominance of one of four Lactobacillus spp., or by a mixed
anaerobic population that might indicate dormant or active
infection such as BV or aerobic vaginitis (Donders, 2015; Vieira-
Baptista et al., 2016). As observed in other studies (Verhelst
et al., 2004; Verstraelen et al., 2009; Lamont et al., 2011; Ravel
et al., 2011; Gajer et al., 2012; Petricevic et al., 2012; McMillan
et al., 2015), the samples from our study population fell into the
described CSTs, with the highest abundance of CSTIII (L. iners,
41.14%) and CSTI (L. crispatus, 29.75%).
Our findings suggest that L. crispatus, and potentially L.
gasseri, might be associated with pregnancies that progress to
term and may be “health” promoting, although we acknowledge
that larger sample sizes would ideally be needed based on the data
gathered here. This is intriguing given the increasing evidence
that L. crispatus, has a number of phenotypic attributes thatmight
predispose to maintenance of a healthy vaginal microbiota able
to out-compete BV-associated bacterial (BVAB) species that are
considered risk factors for PTB (Borges et al., 2014; Ghartey
et al., 2014). Information on L. gasseri is more limited and its
potential role in the vaginal microbiota in relation to PTB is
unclear at present with suggestions that it is more prevalent in
White populations and associated with a more diverse vaginal
microbiota (Verstraelen et al., 2009; Hyman et al., 2014).
While L. crispatus seems to be associated with health and
term delivery, in agreement with others, albeit in different cohort
types (Kindinger et al., 2017), our data indicate that in the
asymptomatic women studied at 26–28 weeks (90%with a history
of PTB), in which ∼29% delivered before 36 weeks (12/41),
PTB may be associated with L. jensenii (CSTV) dominance. We
observed that 25% (>2-fold) of women delivering preterm had
vaginal microflora dominated by L. jensenii compared to 10%
of the women that delivered at term. To our knowledge this
is the first report of such an observation. However, previously
a longitudinal study suggested that in pregnancy L. jensenii
may be indicative of a more unstable microbiota (Verstraelen
et al., 2009), since it was (along with L. iners) associated
with microbiota that transitioned between CSTs (Jakobsson and
Forsum, 2007; Verstraelen et al., 2009). This was also partly
borne out in a recent study by Kindinger et al. (2017), who
showed an association between L. iners and PTB in terms of
transitioningmicrobiota over pregnancy from 16weeks in amore
ethnically diverse cohort than obtained in our second trimester
24–28 weeks study reported here. Contrastingly, L. crispatus
seemed to be associated with a more stable microbiota, a fact
that may influence microbial homeostasis and indicate potential
disturbances that are related to progression to infection and PTB
(Jakobsson and Forsum, 2007; Donders et al., 2009; Walther-
António et al., 2014). Overall this paints a picture of more
investigations with larger cohort sizes being key to studies in this
area.
Deciphering the role of individual Lactobacillus spp.
in PTB is daunting given the dearth of knowledge of the
microbiology of vaginal lactobacilli. More recently emerging
data of genomic sequencing suggest that the genomic
complement of Lactobacillus spp. differs between the four
main Lactobacillus spp., potentially indicating adaptations to
different environmental conditions (Mendes-Soares et al., 2014).
L. crispatus has the largest genome of the four main Lactobacillus
spp. (Witkin and Linhares, 2016), including a plethora of
potential bacteriocin and adhesin genes, but how these are
expressed, or what their roles are in vivo remains unclear (Ojala
et al., 2014).
The low abundance of Bacteroidetes, Gardnerella, and other
BVAB in our dataset was unsurprising given the low prevalence
of BV in our cohort. This may be partly due to the narrow ethnic
mix—a predominantly white population, but is also borne out
of the clinical histories of these women—i.e., no symptomatic
BV-clinically and microbiologically verified. This is in contrast to
some other studies where the presence of Gardnerella and other
anaerobic spp. have been shown to be associated with PTB, but
were conducted in predominantly African–American women in
whom these species are known to be more common (Hillier et al.,
1995; Fredricks et al., 2005; Hyman et al., 2005; Ravel et al., 2011;
Fettweis et al., 2014). This indicates that any observed association
between bacterial species and clinical outcomes in this study
may be independent of BV status as all the study participants
were tested for BV and those with positive results excluded
from the study. However, we acknowledge that our data may be
influenced by our primer set, which may have some inherent bias
against Gardnerella spp. but notably, not other BVAB. However,
in contrast to the study of Kindinger et al. (2017), where similar
primers were used, we did detect Gardnerella in 39 of our 158
samples (albeit at very low levels that in nearly all cases were
not indicative of a mixed anaerobe microbiota). In addition, we
found only a small percentage of samples dominated by mixed
anaerobes (0.63%). This could not be fully explained in the
current study because while our primers contained a potential
mismatch that could reduce detection of Gardnerella spp., they
were well suited for detection of a broad variety of Bacteroidetes
group and Fusobacterium spp. as highlighted by their extensive
use in assessing anaerobe-rich oral and other rich microbiota
samples, including vaginal samples (Lane et al., 1985; Frank et al.,
2008; Kistler et al., 2013; Romero et al., 2014). However, clinical
microbiological analysis conducted by our hospital’s laboratories
revealed a low BV prevalence rate (1.9%) in this study population,
a fact that explains the low proportion of CSTIV-dominated
samples.
Of note is that two samples were dominated by non-
CST species of Lactobacillus, namely L. delbrueckii and L.
helveticus. The significance of this is currently unclear, but
both occurred in women that delivered at term with both
species considered potential probiotic species that are present
in a significant proportion of healthy female vaginal microbiota
(Vasquez et al., 2002; Taverniti and Guglielmetti, 2012). These
data also indicate that there are other dominant lactobacilli in the
human population that may contribute to the maintenance of a
healthy microbiota.
16S rRNA gene sequencing is a powerful tool to establish
the composition of the microbial community of clinical (and
other) niches in relation to health and disease and to identify
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potentially associated organisms. However, one drawback of
this approach is the inability to examine what the overall
functional consequences of the microbiota might be. As a result
we utilized a 1H-NMR approach to assess the levels of six
identified metabolites in the same vaginal fluid samples as used
in the gene sequencing experiments. Our data revealed that
at 26–28 weeks, women who ultimately delivered preterm had
lower succinate levels compared to the term women (Figure 6).
This was somewhat unexpected given previous data indicating
increases in succinate levels associated with BV and PTB (Spiegel
et al., 1980; Ison et al., 1983; Srinivasan et al., 2015). Indeed,
data from a similar cohort of women examined by our team
(though with a lower prevalence of recurrent PTB), but for
which we do not have microbiota data showed a similar but
non-significant trend for succinate (Amabebe et al., 2016a),
while elevated acetate was predictive of PTB in symptomatic
women attending at a late gestation (Amabebe et al., 2016a,b).
This indicates that further confirmatory studies are required.
However, our cohort contained low levels of BV and it is possible
that succinate is linked to the higher levels of L. crispatus
(CSTI), an organism known to produce succinate (McMillan
et al., 2015) compared to other commensal vaginal bacteria (at
least in vitro) and to express metabolic genes for the production
of lactate in vivo (Macklaim et al., 2013). Also, compared to
our previous study where symptomatic women were examined
independently i.e., analyses were based on presentation with
symptoms of preterm labor (Amabebe et al., 2016b), the current
study analyzed CVF metabolites based on CST dominance,
gestational age at sampling, and subsequent delivery outcome.
Indeed, when we analyzed metabolite levels in relation to CST
designation, we observed significantly higher succinate levels
in microbiota dominated by L. crispatus (CSTI) and L. gasseri
(CSTII) compared to L. jensenii (CSTV). While intriguing,
especially given the immunomodulatory effects of succinate
(Al-Mushrif et al., 2000), we must temper this data with the
need for a larger cohort of patients in the same groups and
a sensitive biochemical assay to assess the concentrations of
succinate in vaginal fluid. Nevertheless, in this instance, it could
be that the immunomodulatory actions of succinate inhibiting
chemotaxis and initiation of an adverse inflammatory state could
be protective against inflammation-associated PTB.
We also observed a differential expression of metabolites in
relation to the dominant CSTs in the overall study population
(i.e., 20–22 and 26–28 weeks combined). There were higher
lactate and succinate levels in the CSTI-dominated samples
compared to those dominated by CSTV. Similarly, CSTI-
dominated samples showed higher lactate levels than CSTV
at 20–22 and 26–28 weeks. CSTII-dominated microbiota also
indicated raised succinate levels over CSTV in the overall
cohort and in women studied at 26–28 weeks only. This
was supported by PCoA, which revealed strong clustering of
metabolites according to CST in the total population. Taken
together, the observed differences in metabolite expression
levels in relation to the unique microbiota signature suggests
that the dominant Lactobacillus spp. (CST) rather than
gestational age at sampling seems to influence specific metabolite
profiles.
Our study of vaginal fluid also allowed us to assay the pH of
women in our cohorts. While there was a non-significant trend
to lower pH-values in the term women, women with high pH-
values were not BV positive (Eschenbach et al., 1988; Sheiness
et al., 1992). This is in accordance with the low incidence of
BV in this study population. However, when the vaginal pH
was analyzed in relation to CST, we observed clearly significant
differences between CSTI and other CSTs, particularly CSTV-
dominated samples (pH: 3.8 vs. 4.2). A potential mechanism
for this difference might be the increase in lactate in samples
dominated by CSTI (Figure 6), consistent with several studies
indicating that L. crispatus may decrease vaginal pH in vivo by
producing high amounts of lactate from glycogen deposits in the
vaginal ecosystem (Linhares et al., 2011; Ravel et al., 2011; Witkin
et al., 2013; Aldunate et al., 2015).
In this study, we focused on women at risk of PTB in
whom the risk of another PTB was high. We did not study any
control group of low risk women, matched for gestation, with no
symptoms of PTB.We recognize this as a limitation of the present
study. It is envisaged that in subsequent studies of sufficiently-
powered, larger sample sizes we will explore our observations in
unselected populations of women, including those deemed to be
at low risk of PTB.
In conclusion, our data present a picture of the vaginal
microbiota that tentatively agrees with the potentially beneficial
presence of an L. crispatus/gasseri-dominated microbiota
(CSTI/II) over other lactobacilli, particularly the potentially
detrimental L. jensenii (CSTV). Also, for the first time, we
highlight that L. gasseri may be associated with vaginal health,
albeit in a small, high-risk, largely Caucasian population.
Furthermore, our data suggest that CSTs may influence the
vaginal microenvironment by altering levels of lactate, succinate
and acidity.
Though preliminary, our findings do raise the possibility
that further study of the CST Lactobacilli spp. is warranted.
Importantly, it highlights the need to focus on the influence of
specific lactobacilli-dominated CSTs in larger cohorts of pregnant
women including those at low risk for prematurity.
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